SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-257687
Filing Date
2023-10-17
Accepted
2023-10-17 16:26:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d655533ds3.htm S-3 203082
2 EX-5.1 d655533dex51.htm EX-5.1 35658
3 EX-23.1 d655533dex231.htm EX-23.1 2173
4 EX-FILING FEES d655533dexfilingfees.htm EX-FILING FEES 84097
5 GRAPHIC g655533g17g68.jpg GRAPHIC 51076
  Complete submission text file 0001193125-23-257687.txt   396590
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275053 | Film No.: 231329891
SIC: 2836 Biological Products, (No Diagnostic Substances)